Mumbai, Feb. 28 -- Suven Pharmaceuticals announced that CRISIL has assigned/ reaffirmed the following ratings to the Bank facilities of the Company as under:

Long Term Rating - CRISIL A+/Watch Positive (Continues on 'Rating Watch with Positive Implications')

Short Term Rating - CRISIL A1+ (Reaffirmed)

Published by HT Digital Content Services with permission from Capital Market....